drugset / Press release
Approval of COVID19-study
2022-01-19 · Annexin Pharmaceuticals AB · original annexinpharma.com ↗
Maastricht University Hospital receives approvals to start study with Annexin Pharmaceuticals drug candidate, ANXV, in patients with COVID19.
The release as fetched from its publisher. annexinpharma.com ↗